Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT05446376

Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

Led by University Hospital, Bordeaux · Updated on 2026-02-03

40

Participants Needed

1

Research Sites

101 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

CiGal-EI-TEP is an exploratory study that aim to assess the diagnostic performance of 68Ga Positron emission tomography (PET) / Computed Tomography (CT) for the diagnosis of prosthetic valve infective endocarditis in comparison with the final diagnosis established according to the ESC 2023 criteria, after 3 months of follow-up, by a panel of experts.

CONDITIONS

Official Title

Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • adult patient (over 18 years old);
  • patient with a prosthetic heart valve;
  • patient suspected of infective endocarditis (on clinical and/or microbiological and/or imaging data);
  • patient whose history is discussed in the multidisciplinary meeting dedicated to endocarditis;
  • patient beneficiary of a social security scheme;
  • free, informed and written consent signed by the participant and the investigator.
Not Eligible

You will not qualify if you...

  • pregnant or breastfeeding women;
  • women of childbearing potential not using effective contraception;
  • patients referred to in articles L.1121-5 to L.1121-8 (persons deprived of liberty by judicial or administrative decision, minors, adults subject to a legal protection measure or unable to express their consent);
  • subject in a period of relative exclusion due to another protocol;
  • known contraindication to PET/CT with injection of radiotracers (hypersensitivity to radiopharmaceuticals and/or excipients).

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU de Bordeaux

Bordeaux, France

Actively Recruiting

Loading map...

Research Team

C

Carine GREIB, MD

CONTACT

S

Sandrine FOUCHET

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here